Ovral and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Ovral (ethinyl estradiol; norgestrel), especially for people who are female, 40-49 old, also take Diflucan, and have Pain.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Ovral. It is created by eHealthMe based on reports of 1,503 people who have side effects when taking Ovral from the FDA, and is updated regularly.

What is Ovral?

Ovral has active ingredients of ethinyl estradiol; norgestrel. It is often used in birth control. eHealthMe is studying from 1,571 Ovral users. Check the latest studies of Ovral.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,957 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 07, 2026

1,503 people reported to have side effects when taking Ovral.
Among them, 18 people (1.2%) have Hyperkalemia.

Among these 18 people:

What is the gender of people who have Hyperkalemia when taking Ovral? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Hyperkalemia when taking Ovral? *

What are other drugs people take besides Ovral? *

What are other side effects people have besides Hyperkalemia? *

Headache (pain in head): 15 people, 83.33%
Anaemia (lack of blood): 15 people, 83.33%
Pain: 15 people, 83.33%
Wound Secretion: 13 people, 72.22%
Influenza Like Illness: 13 people, 72.22%
Oral Discomfort (pain or irritation in mouth): 13 people, 72.22%
Neoplasm Malignant (cancer tumour): 13 people, 72.22%
Blood Calcium Decreased: 13 people, 72.22%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 13 people, 72.22%
Bone Cyst: 13 people, 72.22%

What are the existing conditions these people have? *

Pain: 15 people, 83.33%
Nausea And Vomiting: 13 people, 72.22%
Nausea (feeling of having an urge to vomit): 13 people, 72.22%
Multiple Myeloma (cancer of the plasma cells): 13 people, 72.22%
Insomnia (sleeplessness): 13 people, 72.22%
Depression: 13 people, 72.22%
Anaemia (lack of blood): 13 people, 72.22%
Heavy Or Prolong Menstrual Bleeding: 2 people, 11.11%
Blood Culture Positive: 2 people, 11.11%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ovral and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ovral:

Ovral (1,571 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Ovral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,957 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,936 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestrel (the active ingredients of Ovral) and Ovral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.